Log in
Enquire now
‌

US Patent RE49294 DNA vector production system

Patent RE49294 was granted and assigned to Mediphage Bioceuticals on November, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Mediphage Bioceuticals
Mediphage Bioceuticals
0
Current Assignee
Mediphage Bioceuticals
Mediphage Bioceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
RE492940
Patent Inventor Names
Roderick Slavcev0
Nafiseh Nafissi0
Date of Patent
November 15, 2022
0
Patent Application Number
168105040
Date Filed
March 5, 2020
0
Patent Primary Examiner
‌
Bruce R. Campell
0
CPC Code
‌
C12N 15/85
0
‌
C12N 15/70
0
‌
C12N 15/11
0

A vector production system is provided. The system comprises recombinant cells designed to encode at least a first recombinase under the control of an inducible promoter and the cells include an expression vector encoding a nucleic acid of interest within the regulatory elements of the expression vector which are flanked on either side by a target sequence for at least the first recombinase. The vector production system provides an efficient one-step process for producing linear or circular covalently closed vectors that incorporate a nucleic acid sequence of interest.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent RE49294 DNA vector production system

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.